D
Rhythm Pharmaceuticals, Inc. RYTM
$52.34 $1.372.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -3.98% 1.10% 30.92% -170.94% 2.02%
Total Depreciation and Amortization -8.15% -12.90% -11.76% -11.38% -5.66%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 373.87% -16.65% -52.71% 717.01% -50.04%
Change in Net Operating Assets 14.58% 397.91% 59.34% -179.45% 305.32%
Cash from Operations 35.86% 13.80% 29.24% -11.83% 13.58%
Capital Expenditure -- -- -- -- 0.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -6.55% 4.36% -117.77% 62.34% 155.52%
Cash from Investing -6.55% 4.36% -117.77% 62.75% 155.52%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 743.23% -88.54% 311.14% 476.85% -75.05%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -47.94% -115.02% 553.83% -106.00% 3.31%
Cash from Financing 1,481.84% -96.59% 15,248.08% 3,290.23% -86.05%
Foreign Exchange rate Adjustments 608.85% -883.12% -166.37% -182.56% --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,022.38% -123.42% 1,697.11% 63.80% 92.14%
Weiss Ratings